| Dr Joel Saul Salesky, MD | |
|
1000 E Mountain Blvd, Wilkes Barre, PA 18711-0027 | |
| (570) 808-7779 | |
| (570) 808-5390 |
| Full Name | Dr Joel Saul Salesky |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 19 Years |
| Location | 1000 E Mountain Blvd, Wilkes Barre, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346305653 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Geisinger Wyoming Valley Medical Center | Wilkes barre, PA | Hospital |
| Geisinger-community Medical Center | Scranton, PA | Hospital |
| Geisinger Medical Center | Danville, PA | Hospital |
| Geisinger-lewistown Hospital | Lewistown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Geisinger-hm Joint Venture Llc | 1355676370 | 306 |
| Geisinger Clinic | 5395657001 | 2866 |
News Archive
The drive to improve quality in the education sector is similar to that in health care, and lessons from the schools system are relevant to nursing leadership.
Children's Hospital Los Angeles investigators have demonstrated the need to include a growing constituency of obese and overweight children and adults in clinical research, with their study of a key marker for metabolism and body temperature control.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-PCS, an RNAi therapeutic for the treatment of severe hypercholesterolemia.
A new study from the University of Sheffield has shown a new blood test could provide a clue as to why some patients are at higher risk of cardiovascular disease risk after suffering a heart attack.
President Obama's State of the Union speech has so far failed to unite Democrats on a health reform strategy as they "stared down a political nightmare," The Associated Press reports.
› Verified 2 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
The drive to improve quality in the education sector is similar to that in health care, and lessons from the schools system are relevant to nursing leadership.
Children's Hospital Los Angeles investigators have demonstrated the need to include a growing constituency of obese and overweight children and adults in clinical research, with their study of a key marker for metabolism and body temperature control.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-PCS, an RNAi therapeutic for the treatment of severe hypercholesterolemia.
A new study from the University of Sheffield has shown a new blood test could provide a clue as to why some patients are at higher risk of cardiovascular disease risk after suffering a heart attack.
President Obama's State of the Union speech has so far failed to unite Democrats on a health reform strategy as they "stared down a political nightmare," The Associated Press reports.
› Verified 2 days ago
| Entity Name | Geisinger-hm Joint Venture Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144876137 PECOS PAC ID: 1355676370 Enrollment ID: O20190826000803 |
News Archive
The drive to improve quality in the education sector is similar to that in health care, and lessons from the schools system are relevant to nursing leadership.
Children's Hospital Los Angeles investigators have demonstrated the need to include a growing constituency of obese and overweight children and adults in clinical research, with their study of a key marker for metabolism and body temperature control.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-PCS, an RNAi therapeutic for the treatment of severe hypercholesterolemia.
A new study from the University of Sheffield has shown a new blood test could provide a clue as to why some patients are at higher risk of cardiovascular disease risk after suffering a heart attack.
President Obama's State of the Union speech has so far failed to unite Democrats on a health reform strategy as they "stared down a political nightmare," The Associated Press reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joel Saul Salesky, MD 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Dr Joel Saul Salesky, MD 1000 E Mountain Blvd, Wilkes Barre, PA 18711-0027 Ph: (570) 808-7779 |
News Archive
The drive to improve quality in the education sector is similar to that in health care, and lessons from the schools system are relevant to nursing leadership.
Children's Hospital Los Angeles investigators have demonstrated the need to include a growing constituency of obese and overweight children and adults in clinical research, with their study of a key marker for metabolism and body temperature control.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-PCS, an RNAi therapeutic for the treatment of severe hypercholesterolemia.
A new study from the University of Sheffield has shown a new blood test could provide a clue as to why some patients are at higher risk of cardiovascular disease risk after suffering a heart attack.
President Obama's State of the Union speech has so far failed to unite Democrats on a health reform strategy as they "stared down a political nightmare," The Associated Press reports.
› Verified 2 days ago
Dr. Ronald Richterman, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 575 N River St, Wilkes Barre, PA 18764 Phone: 570-696-3283 Fax: 570-696-3268 | |
Brian Carl Klimas, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-7779 Fax: 570-808-5390 | |
Dr. Mohammed A. Talukder, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1000 E Mountain Dr, Dept Of Radiology, Wilkes Barre, PA 18711 Phone: 570-808-7779 Fax: 570-808-2394 | |
Dr. Joseph Daniel Kalowsky, D.O. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1111 E End Blvd, Wilkes Barre, PA 18711 Phone: 570-824-3521 Fax: 570-819-5139 | |
Dr. Arthur Liss, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1000 E Mountain Blvd, Dept Of Radiology, Wilkes Barre, PA 18711 Phone: 570-826-7779 Fax: 570-821-2394 | |
Dr. Samuel Azeze, MD, MPH Radiology Medicare: Accepting Medicare Assignments Practice Location: 575 N River St, Wilkes Barre, PA 18764 Phone: 617-726-2000 | |
Dr. Grace K. Boyle, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1000 E Mountain Blvd, Dept Of Radiology, Wilkes Barre, PA 18711 Phone: 570-826-7779 Fax: 570-821-2394 |